Genovate Biotechnology Co., Ltd. Stock Price

TPEX:4130 Community·NT$3.1b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

4130 Share Price Performance

NT$27.45

7.25 (35.92%)

NT$27.45

7.25 (35.92%)

NT$27.45

Sun, 3 May 26

Share Pricen/a

4130 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet with questionable track record.

2 Risks

0 Rewards

View Full Analysis

Genovate Biotechnology Co., Ltd. Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: 0.10
: 35.95%
: 2.37%
: 0%

View Full Analysis

About 4130

Founded: 1982
Employees: 190
CEO: Chia-Chen Chu
WebsiteView website: www.genovate-bio.com

Genovate Biotechnology Co., Ltd. engages in the research, development, manufacture, production, and sale of products to prevent and treat diseases caused by viruses and bacteria in Taiwan. It provides drugs, APIs, intermediates, and release agents for the treatment of cardiovascular, esophageal, gastrointestinal, cancer, and autoimmune diseases; and controlled-release dosage forms of Western medicine, as well as cosmetics. Genovate Biotechnology Co., Ltd. was founded in 1982 and is based in Hsinchu City, Taiwan.